Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis
jRCT2080220769Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Denosumab with Placebo (2 arms).
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on jRCT2080220769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220769.